发明授权
- 专利标题： Gene expression profiling of EGFR positive cancer
- 专利标题（中）： EGFR阳性癌基因表达谱
-
申请号： US13150799申请日： 2011-06-01
-
公开(公告)号： US08148076B2公开(公告)日： 2012-04-03
- 发明人: Joffre B. Baker , Maureen T. Cronin , Steven Shak , Jose Baselga
- 申请人： Joffre B. Baker , Maureen T. Cronin , Steven Shak , Jose Baselga
- 申请人地址： US CA Redwood City
- 专利权人： Genomic Health, Inc.
- 当前专利权人： Genomic Health, Inc.
- 当前专利权人地址： US CA Redwood City
- 代理机构： Bozicevic, Field & Francis LLP.
- 代理商 Paula A. Borden
- 主分类号： C12Q1/68
- IPC分类号： C12Q1/68 ; C12M1/34 ; C07H21/02 ; C07H21/04
摘要：
The present invention concerns prognostic markers associated with EGFR positive cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed tissue samples of EGFR-expressing cancer, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
公开/授权文献
- US20110245102A1 Gene Expression Profiling of EGFR Positive Cancer 公开/授权日：2011-10-06
信息查询
